Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - Cash on Hand
Cash on Hand as of December 2023 : $1.06 M
According to Yield10 Bioscience's latest financial reports the company has $1.06 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Yield10 Bioscience - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $4.34 M | -72.81% |
| 2021-12-31 | $15.99 M | 64.81% |
| 2020-12-31 | $9.7 M | -12.73% |
| 2019-12-31 | $11.11 M | 92.7% |
| 2018-12-31 | $5.76 M | -60.18% |
| 2017-12-31 | $14.48 M | 98.21% |
| 2016-12-31 | $7.3 M | -40.43% |
| 2015-12-31 | $12.26 M | -38.8% |
| 2014-12-31 | $20.04 M | 4.36% |
| 2013-12-31 | $19.2 M | -56.12% |
| 2012-12-31 | $43.77 M | -43.04% |
| 2011-12-31 | $76.85 M | 24.82% |
| 2010-12-31 | $61.57 M | -33.22% |
| 2009-12-31 | $92.2 M | 1.21% |
| 2008-12-31 | $91.09 M | -16.67% |
| 2007-12-31 | $0.10 B | -10.45% |
| 2006-12-31 | $0.12 B | 3746.25% |
| 2005-12-31 | $3.17 M | -28.75% |
| 2004-12-31 | $4.45 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -87.64% | Bahamas |
 NRC Health
NRC | $6.65 M | 522.94% | 🇺🇸 USA |